Alterations in von Willebrand Factor Antigen in Premature Infants with Respiratory Distress Syndrome and Chronic Lung Disease*
|
|
- Hilda Gaines
- 6 years ago
- Views:
Transcription
1 ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 23, No. 1 Copyright 1993, Institute for Clinical Science, Inc. Alterations in von Willebrand Factor Antigen in Premature Infants with Respiratory Distress Syndrome and Chronic Lung Disease* CELESTE H. PATRICK, M.D., JOHN LAZARCHICK, M.D., and BRENDA S. HORN, M.T. (ASCP) Departments of Pediatrics and Pathology/Laboratory Medicine Medical University of South Carolina Charleston, SC ABSTRACT Elevated levels of von W illebrand Factor Antigen (vwf:ag) may occur in the presence of endothelial injury, a component in the pathology of acute pulmonary insufficiency. The vwf:ag levels were examined in 13 well infants (controls) and 20 infants with respiratory distress syndrome (RDS), nine of whom developed bronchopulmonary dysplasia (BPD). All infants were very low birth weight (730 to 1500 g) and prem ature (25 to 34 weeks estimated gestational age). Plasma samples were obtained at birth and weekly through 28 days of age and frozen at 70 C. The vwf:ag was quantified by the enzyme linked immunosorbent assay (ELISA) m ethod for 138 plasma specimens; in addition, 77 samples were analyzed for multim er pattern by SDS-agarose (1.7 percent) electrophoresis and densitom etric scanning. All groups had elevated mean levels of vwf:ag, compared to adults. Although levels rem ained stable over the four week period, the group of infants with BPD had a significantly high mean level of vw F: Ag at 21 days than those groups without BPD (p < 0.05). Visual examination of vwf m ultim er patterns revealed absence of unusually large vwf multimers and triplet patterns suggestive of increased proteolytic degradation of von W illebrand factor. However, densitometer scanning revealed that samples with higher vwf:ag levels (>200 percent) had increased amounts of moderate to smaller sized multimers, regardless of presence or absence of BPD. It is our conclusion that von W illebrand factor antigen levels are nonspecifically elevated in prem ature infants and that chronic lung disease is associated with even higher plasma values, possibly owing to pulmonary endothelial injury. Send reprint requests to: John Lazarchick, M.D., Department of Pathology/Lab Medicine, Medical University of South Carolina, 171 Ashley Avenue, Charleston, SC /93/ $01.20 Institute for Clinical Science, Inc.
2 40 PATRICK, LAZARCHICK, AND HORN Introduction Factor V III: von W illebrand factor antigen (vw F:Ag) is sy n th esized by megakaryocytes and endothelial cells of arteries and is released into the circulation in resp o n se to various stim uli, including endothelial cell injury.8,9 Low levels of antigen are often associated with a bleeding diathesis, while high concentrations may be noted in certain prim ary throm botic states, including throm botic throm bocytopenic purpura and adult respiratory distress syndrome. Von W illebrand factor circulates as a m ultim er, ranging in size from one to approxim ately 20 X 106 daltons; abnormalities of the structure or proportion of the various m ultimers may also result in bleeding or thrombosis. Adequate levels of normal vwf:ag are essential for platelet adhesion to collagen exposed by damage to the endothelium.11 Severe respiratory failure is characterized by diffuse pulmonary microvascular injury and produces marked increases in Factor V III and von W illebrand factor antigen in adult patients with respiratory failure.4 To explore the alterations of plasma von W illebrand factor antigen in a comparable neonatal population who are at risk for pulmonary endothelial injury, von W illebrand factor antigen levels and multim er patterns in 33 very low birthw eight infants w ere studied. It was hypothesized by us that prem ature newborns with respiratory distress syndrome would have elevated von W illebrand factor antigen levels and alterations in m ultim er patterns. Materials and Methods Blood samples were collected in ethyle n e d ia m in e te tra a c etic acid (EDTA)- anticoagulated tubes from 33 very low birthweight (<1500 gm) infants at birth, on day 3, and w eekly for four weeks. P atients w ere selected as consecutive admissions to the neonatal intensive care unit of the Medical University of South Carolina Children s Hospital Charleston, South Carolina, whose parents provided in fo rm ed co n sen t. S p ecim en s w ere obtained via umbilical vessel catheters or by puncture of peripheral artery or vein. Platelet-poor plasm a was obtained by centrifugation of whole blood at 2500 X g for 20 m inutes at 37 C and stored at -70 C. A total of 136 adequate plasma samples were collected from the infants. A pool of plasma from 20 normal subjects similarly drawn and prepared was stored at 70 C in small aliquots for com parison studies. G roups w ere d iv id e d into control p a tie n ts (13 w ell in fan ts) and sick patients (20 infants with a clinical and x-ray diagnosis of respiratory distress syndrome [RDS]). Upon completion of sample collection, the latter group was further divided into a resolved RDS group (11 infants) and an RDS group who subsequently developed bronchopulm o nary dysplasia (BPD) by chest radiograph findings and 28 day oxygen requirem ent (nine infants). V on W ille b r a n d fa c to r a n tig e n (vw F:A g) assay was p e rfo rm e d by enzym e imm unoassay using the Sandw ich technique.* This technique has been previously described.2 Von W illebrand factor multim er analyses w e re p e rfo rm e d u sin g so d iu m dodecyl sulfate (SDS)-1.7 p ercen t agarose gel electrophoresis.14 Ten jxl of a 1: 10 dilution of test samples were added to each well, and electrophoresis carried out at 20 ma for approximately two hours and then at 3 to 5 ma overnight. M ultimers w ere then transferred from the agarose gel to a nitrocellulose membrane as described by Towbin et al.15 The transblots w ere developed by using a rabbit * ASSERACHROME vwf Diagnostica Stago, Asnieres-sur-seine, France.
3 VON WILLEBRAND FACTOR ANTIGEN IN PREMATURE INFANTS WITH RDS & BPD 41 antihum an vwf antibody as the primary antibody and peroxidase-conjugated goat a n ti-rab b it IgG as the secondary antibody. The membranes were developed with 4-chloro-l-naphthol as the indicator reagent. M ultimeric patterns were examined visually and by densitom etric scanning using the Beckm an Appraise densito m e te r.t T h e m u ltim e ric p a tte rn obtained on electrophoresis and transblot of the control normal pooled plasma was arbitrarily divided into three equal vertical se g m e n ts d e s ig n a te d as sm all, medium, and large multimers. The multimeric patterns on all test samples were th e n c o m p a re d to th e d is trib u tio n o b ta in e d u sin g th is norm al p o o led plasma as the standard. All Factor VIII: von W illebrand factor antigen results are expressed relative to pooled normal plasm a (100 U per dl) obtained from 20 healthy donors. R esp irato ry d istress was m anaged using conventional ventilation with an effort to keep p C 0 2 betw een 45 and 55 torr, ph g reater than 7.25, and p 0 2 greater than 50 torr. Other medical managem ent included nutritional support, antibiotics w here clinically indicated, and enteral or parenteral diuretics for treatm ent of fluid retention associated w ith bronchopulm onary dysplasia. S ta tistical com parisons w ere p e r form ed using analysis of variance for main effects of tim e and group. Additionally, group tim e interactions were examined. Adjustm ents w ere m ade for m ultiple com parisons using the Bonferroni m ethod. D ifferences were considered statistically significant w hen p < Results Com parison of the groups by birthw eight and gestational age is presented t Beckman Instrum ents, Inc., Palo Alto, CA in table I. There was no statistical difference betw een these groups, although the control patients tended to be slightly heavier and more advanced in gestational age. Mean levels of von W illebrand factor antigen in all groups were higher than adult normal values (upper lim it 150 j, per dl)). Comparison of group m ean values in each time period betw een control infants and those with resolved RDS, revealed no statistical difference over 28 days (table II). At three weeks of age, however, infants who eventually developed bronchopulm onary dysplasia had significantly elevated von W illebrand factor antigen levels versus controls or resolved RDS infants (p <.05, figure 1). Values of vwf:ag in infants with BPD tended to be higher for each sampling interval. Antigen levels did not correlate with the degree of severity of BPD, as m easured by oxygen requirem ents and radiological evidence of fibrosis. Visual inspection of m ultim ers did reveal a qualitative difference in patterns betw een both of these groups and the normal pool plasma (figure 2). No ultra high m olecular w eight (HMW) m ultimers were evident in either the BPD or h y a lin e m em b ran e d ise a s e (H M D ) groups. The HMW multimers were relatively decreased in both of these groups com pared to the pattern seen w ith normal pool plasma. The triplet structure not only had a prom inent central band simi- TABLE I Population Characteristics * Number Weight:grams GA: weeks Controls (±216) 31.0 (±2.2) RDS (±181) 29.0 (± 1.5) RDS with BPD (± 191) 28.7 (± 2.7) * (± standard error of the mean). GA = gestational age. RDS = respiratory distress syndrome. BPD = bronchopulmonary dysplasia.
4 42 PATRICK, LAZARCHICK, AND HORN TABLE II Group Means of von Willebrand Factor Antigen (± SEM) for Each Study Period (% of Standard) Day Controls RDS RDS with BPD ± 71 (13) (7) 272 ± 62 (7) ± 87 (4) 209 ± 75(11) 247 ± 179 (9) ± 72 (9) 237 ± 93(11) 308 ± 135 (8) ± 90 (11) 254 ± 64(10) 332 ± 108 (8) ± 67 (12) 230 ± 76 (9) (8) (11) 228 ± 102 (7) (7) RDS = Respiratory distress syndrome. BPD = bronchopulmonary dysplasia. Numbers In parentheses are numbers of samples analyzed. lar to the control plasma but also minor bands, especially evident in the lower molecular weight m ultim er triplets. No aberrant or extraneous bands were noted in e ith e r study group. D ensitom etric scanning, how ever, did not show any striking alteration of patterns in those individuals with von W illebrand antigen levels w ithin the normal adult range (figure 3). H igher von W illebrand factor antigen levels, i.e., those over 200 percent activity, were associated with increased amounts of the moderate to smaller size m ultim ers, regardless of the group in which the infant was categorized. Of note is that four patients in the RDS group who developed sepsis and died within the first 28 days of life had very high levels of von W illebrand factor antigen (>250 percent activity), the highest value being 592 percent. Discussion Von W illebrand factor antigen, both quantitative and qualitative, has been evaluated previously in both healthy and ill newborns and adults.3 4,7,10 18 N eonatal levels of von W illebrand factor have been reported to be elevated compared to adults, with the highest values in ill newborns. Preterm infants have levels comparable to terms, and levels in both groups decrease to adult concentrations by six m onths chronologic age.1,12 The aim of this study was to compare a control group of w ell neonates to a group of infants w ith the specific diagno- F ig u r e 1. T im e course of changes in the von W illebrand factor antigen (vwf:ag) in the group of infants with hyaline membrane disease (HHMD) and those who developed bronchopulmonary dysplasia (BPD). Mean and standard deviations are indicated for each group and tim e period. DAY
5 VON WILLEBRAND FACTOR ANTIGEN IN PREMATURE INFANTS WITH RDS & BPD We if v m * Ijfe t* * m FIGURE 2. Electrophoretic multimeric profile of von Willebrand antigen from normal pooled plasma (NPP, lanes 4 and 5), plasma from patients with bronchopulmonary dysplasia (BPD, lanes 1, 2, and 3) and plasma from patient with hyaline membrane disease (HMD, lanes 6, 7, 8, and 9) following sodium dodecyl sulfate (SDS)-agarose (1.7 percent) gel electrophoresis, nitrocellulose blotting and immunoperoxidase development. sis of acute lung disease, half of whom ultim ately d eveloped the chronic lung disease bronchopulm onary dysplasia. It was c o n firm ed by us th a t p rem a tu re infants have levels of vw F:Ag higher than normal adults. O ur study population included m ore prem ature and extremely low birthw eight infants than previously published surveys;1,12 group m ean val ues for vw F:A g w ere h ig h e r than in these reports, perhaps reflecting extreme immaturity. Although the m echanism has not been elucidated, higher levels could result from increased production of the m olecule by endo th elial cells w ith or w ithout increased proteolysis.6 An alter n a t i v e e x p l a n a t i o n c o u ld in v o k e d e c re a s e d c le a ra n c e or m e ta b o lis m owing to the relatively poor renal func tion in e x tre m e ly p re m a tu re in fan ts, since there are reported to be increased levels in adults with renal failure.12 It w as also fo u n d by th e p r e s e n t authors that infants with respiratory dis tress syndrom e who continued to have pulm onary insufficiency at three weeks of age had even higher levels of vwf:ag versus those with no disease or in whom acute disease had resolved. O ur data are som ew hat consistent with that of Carval h o s study of 100 ad u lt p a tie n ts w ith acute lung injury4 in that our study found a correlation of high von W illebrand fac tor antigen levels in ventilated patients
6 44 PATRICK, LAZARCHICK, AND HORN Greyvalue NPP: 100% activity Greyvalue BPD: 348% activity A. h A V F i g u r e 3. D ensitometrie scanning of the von Willebrand antigen multimeric profile following electrophoresis of normal pooled plasm a (NPP, top), plasma from a patient with bronchopulmonary dysplasia (BPD, middle), and plasma from a patient w ith hyaline m e m b r a n e d i s e a s e (HMD, bottom). e 100 Greyvalue.w zee 400 No BPD: 296% activity POINTS
7 VON WILLEBRAND FACTOR ANTIGEN IN PREMATURE INFANTS WITH RDS & BPD 45 presum ed to be at risk for pulm onary endothelial injury. D espite surfactant deficiency and the potential for ventilator in d u ced barotraum a in these infants, there was not an exaggerated increase in vwf:ag in the prem ature infants with acute pulm onary insufficiency versus w ell controls. This disparity betw een the response of prem ature infants and adults with acute respiratory failure can not be fully explained, but it can be speculated that prem ature infants may be releasing vwf:ag at the maximal rate owing to stress associated with perinatal adaptation. Alternatively, the damaged lung in adults and neonates with acute respiratory failure may release elastase, or o th er p ro teo ly tic enzym es w hich destroy or alter the molecule, although at different rates. The relative decrease of HMW multimers in both study groups and the atypical triplet pattern, especially prominent in the lower molecular weight m ultimer triplets, are consistent w ith increased endothelial cell release of von W illebrand factor with subsequent proteolysis of the HMW multimers. This increase in sm aller to m oderate size m ultim ers is similar to the findings observed by Brenner et al3 in a group of obstetric patients with pregnancy-induced hypertension, a disorder associated w ith m icroangiopathy and en d o th elial cell injury. O ur group did not study the crossed immunoelectrophoresis pattern of vw F:Ag as Carvalho4 did; however, our findings of increased amounts of small and moderate sized multimers when levels are elevated may be analogous to a shift in electrophoretic patterns toward the faster migrating (and therefore smaller) components seen in adult patients with respiratory failure. The so called ultra large vwf multimers (ULvWFM) noted by W einstein et al18 in a study of cord blood samples was not visualized by us. There was no correlation of the degree of chronic lung w ith the levels of von W illebrand factor antigen, which may reflect the heterogeneity of the clinical diagnosis of bronchopulm onary dysplasia. The am ount of endothelial stim ulation or damage necessary to cause the release of von W illebrand factor into the circulation is difficult to quantitate in vivo, even though cultured hum an endothelial cells can be stim ulated to release vwf:ag by treatm ent w ith trypsin and epinephrine.16 Again, enzymes responsible for the metabolism of factor V III are produced in lung tissue; the immature or inflamed lung may alter the m etabolism of circulating antigen, changing either the qualitative or quantitative m easurem ents. The finding that von W illebrand factor antigen levels are extremely high in the presence of fatal sepsis is of interest. The release of tumor necrosis factor (TNF) and interleukin-1 (IL-1) following exposure to bacterial endotoxin is well docum ented.5 13 W hether the rise in vwf:ag during sepsis is a parallel phenom enon related to nonspecific endothelial dam age or is caused by high levels of TNF and/or IL-1 is an area for further investigation. An additional confounding factor with sepsis is the possible alteration in m etabolism and clearance of vw F:Ag in th e h e m o d y n a m ic a lly u n s ta b le infant; changes in renal and/or pulmonary physiology could be responsible for excessive release or decreased excretion of the molecule. Conclusion It is our conclusion that very low birthweight premature infants have elevated levels of von W illebrand factor antigen compared to adults; in the presence of chronic lung injury or sepsis, there is a fu rth e r in c re a se in a n tig e n le v e ls. D etailed examination of qualitative characteristics of the antigen (i.e., multimeric analysis) reveals extrem e elevations (>200 percent of norm al values) to be
8 46 PATRICK, LAZARCHICK, AND HORN associated with increases in the small to m oderate sized m ultim ers. T he m echanism ^) inducing release in th e circulation is unknown. References 1. An d r e w, M., P a e s, B and MILNER, R.: Development of the human coagulation system in the healthy preterm infant. Blood 72: , B a r t l e t t, A., D o r m a n d y, K. M., H a w k e y, C. M., St a b l e f o r t h, P., and V o l l e r, A.: Factor V I II related antigen: M easurem ent by enzyme immunoassay. Brit. Med. J. 1: , B r e n n e r, B., Z w a n g, E., B r o n s h t e i n, M., and S e l ig s o h n, U. Von Willebrand factor multimer patterns in pregnancy induced hypertension. Thromb. Haemost. 62: , C a r v a l h o, A. C., B e l l m a n, S. M., Sa u l l o, V. J., QUINN, D., and ZAPOL, W. M.: Altered factor VIII in acute respiratory failure. New Engl. J. Med. 307: , DlNARELLA, C. A.: Interleukin-1 and the pathogenesis of the acute phase response. New Engl. J. Med. 311: , H a m il t o n, K. K., F r e t t o, L. S., G r ie r s o n, D. S., and M c Ke e, P. A.: Effects of plasmin on von Willebrand factor multimers. Degradation in vitro and stimulation of release in vivo. J. Clin. Invest. 76: , F u k u i, H., T a k a s e, T., I k a r i, H., M u r a k a m i, Y., O k u h o, Y., and N a k a m u r a, K.: Factor VIII procoagulant activity, factor VIII related antigen, and von Willebrand factor in newborn cord blood. Brit. J. Haematol. 42: , Ja f f e, E. A., H o y e r, L. W., and N a c h m a n, R. L.: Synthesis of antihemophilic factor antigen by cultured human endothelial cells. J. Clin. Invest. 52: , J o h n s o n, A. R.: Human pulmonary endothelial cells in culture: Activities of cells from arteries and cells from veins. J. Clin. Invest. 65: , Ka t z, J. A., M o a k e, J. L., M c P h e r s o n, P. D., W e i n s t e in, M. J., M o is e, K. J., C a r p e n t e r, F. J., and Sa l a, D. J.: Relationship between human developm ent and disappearance of unusually large von Willebrand factor multimers from plasma. Blood 73: , Ke s s l e r, C. M., F l o y d, C. M., Ric k, M. E., Kr i z e k, D. M., L e e, S. L., and G r a l n ic k, H. R.: Collagen-factor VIII/von Willebrand factor protein interaction. Blood 63: , Kr i e s, R., J ü r g e n s, H. Hv., V o s s, H., and G ö BEL, U.: Clinical relevance of factor VIII:C and factor VIII R: Ag determination in newborns. Eur. J. Pediatr. 137: , N a t a n s o n, C., E ic h e r n o l z, P. W., and D a n n e r, R. L.: Endotoxin and tumor necrosis factor challengers in dogs simulate the cardiovascular profile of human septic shock. J. Exp. Med. 169: , R u g g e r i, Z. M. and Z im m e r m a n, T. S.: The complex multimeric composition 2 of factor VIII/von Willebrand factor. Blood 57: , T o w b in, H. and GORDON, J.: Immunoblotting and dot immunobinding: Current status and outlook. Immunol. Methods 72: , W a l l, R. T., C o u n t s, R. B., H a r k e r, L. A., and S t r ik e r, G. E.: Binding and release of factor VIII/von W illebrand s factor by human endothelial cells. Brit. J. Haemotol. 46: , W a r k e l l, R. P., J r., H u l t o n, M. B., and C o l - l e r, B. S.: Increased factor VIII/von Willebrand factor antigen and von Willebrand factor activity in renal failure. Am. J. Med. 66: , W e i n s t e in, M. J., B l a n c h a r d, R., M o a k e, J. L., V o s b u r g h, E., a n d M o is e, K.: Fetal and neonatal von Willebrand factor (vwf) is unusually large and similar to vwf in patients with thrombotic thrombocytopenic purpura. Brit. J. Haematol. 72:68 72, 1989.
A Comparison of two Macroscopic Platelet Agglutination Assays for von Willebrand Factor
ANNALS O F CLINICAL AND LABORATORY SC IEN CE, Vol. 20, No. 1 Copyright 1990, Institute for Clinical Science, Inc. A Comparison of two Macroscopic Platelet Agglutination Assays for von Willebrand Factor
More informationSensitivity of Serum Fructosamine in Short Term Glycemic Control
A N N A L S O F C L IN IC A L A N D L A B O R A T O R Y S C IE N C E, Vol. 19, N o. 2 Copyright 1989, Institute for Clinical Science, Inc. Sensitivity of Serum Fructosamine in Short Term Glycemic Control
More informationE levated Prolactin Level in Prostates with Latent Carcinoma
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 17, No. 3 Copyright 1987, Institute for Clinical Science, Inc. E levated Prolactin Level in Prostates with Latent Carcinoma RYUICHI YATANI, M.D.,* ITSUO
More informationAcquired von Willebrand s Disease Following Bone Marrow Transplantation*
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 24, No. 3 Copyright 1994, Institute for Clinical Science, Inc. Acquired von Willebrand s Disease Following Bone Marrow Transplantation* JOHN LAZARCHICK,
More informationReemergence of the International Normalized Ratio for the Standardization of Prothrombin Time*
ANNALS O F CLINICAL AND LABORATORY SCIEN CE, Vol. 23, No. 3 Copyright 1993, Institute for Clinical Science, Inc. Reemergence of the International Normalized Ratio for the Standardization of Prothrombin
More informationThyroid Screening in the Newborn: Utah Experience
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 13, No. 1 Copyright 1983, Institute for Clinical Science, Inc. Thyroid Screening in the Newborn: Utah Experience BRUCE A. BUEHLER. M.D.,* MELVIN J. GORTATOUSKI,
More informationEffects of Alcohol on Visual, Cognitive & Motor Performances Related to a Complex Manual Control Task
Effects of Alcohol on Visual, Cognitive & Motor Performances Related to a Complex Manual Control Task R obert S. K ennedy*, Janet J. Turnage*, D eborah L. H arm ** and Julie M. Drexler*** *Essex Corporation,
More informationAcquired Coagulopathy Owing to Parenteral Cefamandole: Renal Failure as a Predisposing Factor*
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 13, No. 5 Copyright 1983, Institute for Clinical Science, Inc. Acquired Coagulopathy Owing to Parenteral Cefamandole: Renal Failure as a Predisposing Factor*
More informationLONG DIALYSIS SESSIONS (DAILY, NOCTURNAL ETC) Ercan Ok, Izm ir, Turkey. Chair: Mustafa Arici, Ankara, Turkey Bernard Canaud, Montpellier, France
LONG DIALYSIS SESSIONS (DAILY, NOCTURNAL ETC) Ercan Ok, Izm ir, Turkey Chair: Mustafa Arici, Ankara, Turkey Bernard Canaud, Montpellier, France Prof Ercan Ok Divis ion of N ephrology E ge U nivers ity
More informationBehzad Poopak, DCLS PhD
Behzad Poopak, DCLS PhD Test Report Name Age Critical Low HEMATOLOGY Activated Partial Thromboplastin Time, Plasma Critical High - 150 sec Units Fibrinogen 60 - mg/dl INR (International Normalizing
More informationProblems with Outliers in Breath Alcohol Testing
Problems with Outliers in Breath Alcohol Testing Jo c h e n W ilske Blood alcohol concentration (BAC) and impairment o f driving skills are related so closely, that statutory drink-drive limits are accepted
More informationHLA Alloimmunization with Leukocyte Concentrates from HLA-matched and HLA-non-m atched Donors in Patients with H unter s Syndrom e*
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 15, No. 5 Copyright 1985, Institute for Clinical Science, Inc. HLA Alloimmunization with Leukocyte Concentrates from HLA-matched and HLA-non-m atched Donors
More informationProtein S and Thrombosis*
ANNALS O F CLINICAL AND LABORATORY SCIEN CE, Vol. 19, No. 3 Copyright 1989, Institute for Clinical Science, Inc. Protein S and Thrombosis* ROBIN L. GRAVES-HOAGLAND, P h.d. and FR ED ER IC K J. WALKER,
More informationControlled-Release Carbidopa-Levodopa (Sinemet) in Combination with Standard Sinemet in Advanced Parkinson s Disease
ANNALS O F CLINICAL AND LABORATORY SCIEN CE, Vol. 19, No. 2 Copyright 1989, Institute for Clinical Science, Inc. Controlled-Release Carbidopa-Levodopa (Sinemet) in Combination with Standard Sinemet in
More informationViscoelastic Measurement of Clot Formation: A New Test of Platelet Function
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 13, No. 2 Copyright 1983, Institute for Clinical Science, Inc. Viscoelastic Measurement of Clot Formation: A New Test of Platelet Function ABDUS SALEEM,
More informationThe Role of Amniotic Fluid Phospholipids in Determining Fetal Lung Maturity
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 12, No. 4 Copyright 1982, Institute for Clinical Science, Inc. The Role of Amniotic Fluid Phospholipids in Determining Fetal Lung Maturity ALEXANDROS A.
More informationCoagulation Disorders. Dr. Muhammad Shamim Assistant Professor, BMU
Coagulation Disorders Dr. Muhammad Shamim Assistant Professor, BMU 1 Introduction Local Vs. General Hematoma & Joint bleed Coagulation Skin/Mucosal Petechiae & Purpura PLT wound / surgical bleeding Immediate
More informationEDUCATIONAL COMMENTARY PLATELET DISORDERS
EDUCATIONAL COMMENTARY PLATELET DISORDERS Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain FREE CME/CMLE credits click on Earn
More informationThrombotic Thrombocytopenic Purpura and the Role of ADAMTS-13
Thrombotic Thrombocytopenic Purpura and the Role of ADAMTS-13 Mark Cunningham,MD Director, Hematology Laboratory Department of Pathology University of Kansas Medical Center College of American Pathologists
More informationA Supplement to Alkaline Phosphatase Fractionations: Utilization of Gamma- Glutamyl Transpeptidase and Hydroxyproline Assays
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 8, No. 2 Copyright 1978, Institute for Clinical Science A Supplement to Alkaline Phosphatase Fractionations: Utilization of Gamma- Glutamyl Transpeptidase
More informationResearch Roundtable Summary
Research Roundtable Summary 10 TENTH in a Series of Seminars on MCHB-funded Research Projects Early Cortisol Deficiency and Bronchopulmonary Dysplasia October 18, 1995 Parklawn Building Potomac Conference
More informationHEME 10 Bleeding Disorders
HEME 10 Bleeding Disorders When injury occurs, three mechanisms occur Blood vessels Primary hemostasis Secondary hemostasis Diseases of the blood vessels Platelet disorders Thrombocytopenia Functional
More informationThrombosis and Coagulation Abnormalities Associated with Cancer
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 24, No. 1 Copyright 1994, Institute for Clinical Science, Inc. Thrombosis and Coagulation Abnormalities Associated with Cancer ARMAND B. GLASSMAN, M.D. and
More informationROLE OF EARLY POSTNATAL DEXAMETHASONE IN RESPIRATORY DISTRESS SYNDROME
INDIAN PEDIATRICS VOLUME 35-FEBRUAKY 1998 ROLE OF EARLY POSTNATAL DEXAMETHASONE IN RESPIRATORY DISTRESS SYNDROME Kanya Mukhopadhyay, Praveen Kumar and Anil Narang From the Division of Neonatology, Department
More informationImproved Immunodiagnosis of Neutrophil Dysfunction in the Newborn and Infant
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 12, No. 2 Copyright 1982, Institute for Clinical Science, Inc. Improved Immunodiagnosis of Neutrophil Dysfunction in the Newborn and Infant ALAN B. LOREN,
More informationComplications of ECLS. Rajasekhar Malyala, MD Assistant Professor, Surgery University of Kentucky
Complications of ECLS Rajasekhar Malyala, MD Assistant Professor, Surgery University of Kentucky Faculty Disclosure No financial Disclosures Education Need/Practice Gap Recommendations and guidelines regarding
More informationEffects o f Oral Salt Load on Arginine-Vasopressin Secretion in N orm al Subjects*
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 17, No. 5 Copyright 1987, Institute for Clinical Science, Inc. Effects o f Oral Salt Load on Arginine-Vasopressin Secretion in N orm al Subjects* LETIZIA
More informationGenetic examination of diseases affecting bone development. and structure in newborns
Genetic examination of diseases affecting bone development and structure in newborns Examination of molecular genetic markers in osteopenic preterm infants PhD Thesis Simone Funke, MD University of Pécs
More informationSTUDIES OF R H E U M A T IC D IS E A S E 1. Ross L. G a u l d a n d F r a n c e s E. M. R ea d 2
STUDIES OF R H E U M A T IC D IS E A S E 1 I I I. F A M I L I A L A S S O C IA T IO N A N D A G G R E G A T IO N I N R H E U M A T I C D IS E A S E Ross L. G a u l d a n d F r a n c e s E. M. R ea d 2
More information12th International Scientific Conference «Science and Society» London, November 2017 MEDICINE
MEDICINE Li T.A., Maltabarova N.A. SEVERE BRONCHOPULMONARY DYSPLASIA AND PEDIATRIC ACUTE RESPIRATORY DISTRESS SYNDROME. RESEMBLANCE AND CONTRAST Li Tatyana Anatolyevna, PhD doctoral student, Department
More informationScreening Hospitalized Injured Drivers and Other Trauma Victims for Alcoholism Using Two Questions
Screening Hospitalized Injured Drivers and Other Trauma Victims for Alcoholism Using Two Questions C arl A. S o d e r str o m, M.D.,1 P a tricia C. D isc h in g e r, P h.d.,2 G ord on S. S m ith, M.D.3
More informationClinical Trial of Young Red Blood Cells Prepared by Apheresis
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 16, No. 6 Copyright 1986, Institute for Clinical Science, Inc. Clinical Trial of Young Red Blood Cells Prepared by Apheresis PATRICIA PISCIOTTO, M.D.,* THOMAS
More informationAn Overview of Bronchopulmonary Dysplasia and Chronic Lung Disease in Infancy
An Overview of Bronchopulmonary Dysplasia and Chronic Lung Disease in Infancy Housekeeping: I have no financial disclosures Learning objectives: Develop an understanding of bronchopulmonary dysplasia (BPD)
More informationClinical Correlates in Patients with Elevated Platelet-Associated Immunoglobulins*!"
ANNALS O F CLINICAL AND LABORATORY SCIENCE, Vol. 18, No. 1 Copyright 1988, Institute for Clinical Science, Inc. Clinical Correlates in Patients with Elevated Platelet-Associated Immunoglobulins*!" MARK
More informationThe control patients had at least the combination of cardiovascular failure necessitating vasoactive
ELECTRONIC SUPPLEMENTARY MATERIAL Material and methods Patients The control patients had at least the combination of cardiovascular failure necessitating vasoactive medication, respiratory failure necessitating
More informationSerum Calcitonin in Thyroid Disorders and in Pheochromocytoma Kindred*
ANNALS O F CLINICAL AND LABORATORY SCIEN CE, Vol. 16, No. 2 Copyright 1986, Institute for Clinical Science, Inc. Serum Calcitonin in Thyroid Disorders in Pheochromocytoma Kindred* F. J. H ORNICEK, P H.D.,t$
More informationHemodynamic Disorders, Thrombosis, and Shock. Richard A. McPherson, M.D.
Hemodynamic Disorders, Thrombosis, and Shock Richard A. McPherson, M.D. Edema The accumulation of abnormal amounts of fluid in intercellular spaces of body cavities. Inflammation and release of mediators
More informationVTE in Children: Practical Issues
VTE in Children: Practical Issues Wasil Jastaniah MBBS,FAAP,FRCPC Consultant Pediatric Hem/Onc/BMT May 2012 Top 10 Reasons Why Pediatric VTE is Different 1. Social, ethical, and legal implications. 2.
More informationPATENT DUCTUS ARTERIOSUS IN THE PRETERM INFANT EVIDENCE FOR & AGAINST TREATMENT
PATENT DUCTUS ARTERIOSUS IN THE PRETERM INFANT EVIDENCE FOR & AGAINST TREATMENT Dr. Youssef Abou Zanouna, FRCPI, FACC Consultant Pediatric Cardiologist King Fahd Military Medical Complex Dhahran Introduction
More informationSUPPLEMENTARY INFORMATION
SUPPLEMENTRY INFORMTION doi:10.1038/nature11808 NT Phen Met ICR Oligo FCCP pmpk tmpk Supplemental figure 1. -. Primary hepatocytes were treated with 250 um Phenformin, 1 mm Metformin 250 um ICR, 100 nm
More informationSAMPLE. V.12.1 Special Report: Very Low Birthweight Neonates. I. Introduction
I. Introduction V.12.1 Special Report: Very Low Birthweight Neonates The delivery of a very low birth weight infant continues to present many challenges to families and health care providers in spite of
More informationDiagnosis and Management of Von Willebrand Disease
CLINICAL VIGNETTE Diagnosis and Management of Von Willebrand Disease Olga Olevsky, M.D. and Stephen Wong, M.D. Von Willebrand s Disease is the most common inherited bleeding disorder. Low levels of Von
More informationLipid Peroxidation and Pulmonary Hyaline Membranes of the Newborn:
ANNALS OF CLINICAL AND LABORATORY SCIEN CE, Vol. 11, No. 1 Copyright 1981, Institute for Clinical Science, Inc. Lipid Peroxidation and Pulmonary yaline Membranes of the Newborn: A istochemical, Fluorescent
More informationApproach to bleeding disorders &treatment. by RAJESH.N General medicine post graduate
Approach to bleeding disorders &treatment by RAJESH.N General medicine post graduate 2 Approach to a patient of bleeding diathesis 1. Clinical evaluation: History, Clinical features 2. Laboratory approach:
More informationA Hemoglobin A1C Immunoassay Method Not Affected By Carbamylated Hemoglobin*
ANNALS O F CLIN ICA L AND LABORATORY SCIEN CE, Vol. 25, No. 1 Copyright 1995, Institute for Clinical Science, Inc. A Hemoglobin A1C Immunoassay Method Not Affected By Carbamylated Hemoglobin* ANDREA M.
More informationHyaline membrane disease. By : Dr. Ch Sarishma Peadiatric Pg
Hyaline membrane disease By : Dr. Ch Sarishma Peadiatric Pg Also called Respiratory distress syndrome. It occurs primarily in premature infants; its incidence is inversely related to gestational age and
More informationReview of Neonatal Respiratory Problems
Review of Neonatal Respiratory Problems Respiratory Distress Occurs in about 7% of infants Clinical presentation includes: Apnea Cyanosis Grunting Inspiratory stridor Nasal flaring Poor feeding Tachypnea
More informationAssessment of Cellular Immune Response to Cancer of the Breast
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 9, No. 6 Copyright 1979, Institute for Clinical Science, Inc. Assessment of Cellular Immune Response to Cancer of the Breast RONALD B. HERBERM AN, M.D. Laboratory
More informationvon Willebrand Disease
von Willebrand Disease Jeremy Robertson Paediatric Haematologist Royal Children s s Hospital & Pathology Queensland Foglo,, April 1924: the journey begins Oskar and Augusta sail to Helsinki... ...to o
More informationPatent Ductus Arteriosus: Philosophy or Pathology?
Patent Ductus Arteriosus: Philosophy or Pathology? Disclosure Ray Sato, MD is a speaker for Prolacta Biosciences, Inc. This presentation will discuss off-label uses of acetaminophen and ibuprofen. RAY
More informationWisconsin, Madison) to clot at room temperature in a 50-ml. centrifuge tube. After retraction of the clot had begun, the tube and contents
ELECTROPHORETIC ANALYSIS OF ANTE- AND POSTMORTEM SERUM IN DIFFERENT DISEASES' By PHILIP P. COHEN, FRANCES L. THOMPSON, AND GEORGE A. NITSHE, JR. (From the Departments of Physiological Chemistry and Medscine,
More informationM onitoring of Drugs in Breast Milk
ANNALS O F CLIN IC A L A N D LABORATORY SC IE N C E, Vol. 15, No. 2 Copyright 1985, Institute for Clinical Science, Inc. M onitoring of Drugs in Breast Milk STEVEN H. Y. W ONG, P h.d. Department of Laboratory
More informationCover Page. The handle holds various files of this Leiden University dissertation
Cover Page The handle http://hdl.handle.net/1887/37409 holds various files of this Leiden University dissertation Author: Engbers, Marissa Title: Conventional and age-specific risk factors for venous thrombosis
More informationRapid Enzymatic Determination of Amylase in Serum and Urine Using a Centrifugal Analyzer*
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 9, No. 5 Copyright 1979, Institute for Clinical Science, Inc. Rapid Enzymatic Determination of Amylase in Serum and Urine Using a Centrifugal Analyzer* STEVEN
More informationdisease, bronchopulmonary dysplasia, pulmonary hypoplasia and congenital diaphragmatic hernia.
Neonatal Chest Imaging - What the Nurse Should Know Expires Monday, April 30, 2018 Nursing Michael J. Diament, M.D. Objectives 1. Describe a good technique for positioning a neonate for the purpose of
More informationProgestin-only methods Type or dose of progestagen
Progestin-only contraception and beneficial effects on migraine Conflicts of interest A d v ise r a n d le ctu re r fo r E X E LT IS Le ctu re s a n d A d v iso ry b o a rd s B aye r Le ctu re s a n d
More informationBleeding and Thrombotic Disorders. Kristine Krafts, M.D.
Bleeding and Thrombotic Disorders Kristine Krafts, M.D. Bleeding and Thrombotic Disorders Bleeding disorders von Willebrand disease Hemophilia A and B DIC TTP/HUS ITP Thrombotic disorders Factor V Leiden
More informationLifeBridge Health Transfusion Service Sinai Hospital of Baltimore Northwest Hospital Center BQA Transfusion Criteria Version#2 POLICY NO.
LifeBridge Health Transfusion Service Sinai Hospital of Baltimore Northwest Hospital Center BQA 1011.02 Transfusion Criteria Version#2 Department POLICY NO. PAGE NO. Blood Bank Quality Assurance Manual
More informationErythrocyte Uroporphyrinogen I Synthase Activity as an Indicator of Acute Porphyria
A N N A L S O F C L IN IC A L A N D L A B O R A T O R Y S C IE N C E, Vol. 19, N o. 2 Copyright 1989, Institute for Clinical Science, Inc. Erythrocyte Uroporphyrinogen I Synthase Activity as an Indicator
More informationLong-Term Efficacy of Controlled-Release Carbidopa/Levodopa in Patients with Advanced Parkinson s Disease*
ANNALS O F CLINICAL AND LABORATORY SCIEN CE, Vol. 19, 6 Copyright 1989, Institute for Clinical Science, Inc. Long-Term Efficacy of Controlled-Release Carbidopa/Levodopa in Patients with Advanced Parkinson
More informationPulmonary Vascular Disease in BPD. BrochBorc. Late Pulmonary Hypertension is Associated with Poor Survival in BPD
Pulmonary Vascular Disease in PD Steven H. bman, MD Professor of Pediatrics Director, Pediatric Heart Lung enter University of olorado School of Medicine and hildren s Hospital olorado urora O Dr. Steve
More informationCA-549: Immunohistochemistry and Serum Levels in Breast Carcinoma and Other Neoplasms*
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 19, No. 6 Copyright 1989, Institute for Clinical Science, Inc. CA-549: Immunohistochemistry and Serum Levels in Breast Carcinoma and Other Neoplasms* MUHAMMAD
More informationExtensive cystic periventricular leukomalacia following early-onset group B streptococcal sepsis in a very low birth weight infant
SWISS SOCIETY OF NEONATOLOGY Extensive cystic periventricular leukomalacia following early-onset group B streptococcal sepsis in a very low birth weight infant July 2012 2 Berger TM, Caduff JC, Neonatal
More informationAEROSURF Phase 2 Program Update Investor Conference Call
AEROSURF Phase 2 Program Update Investor Conference Call November 12, 2015 Forward Looking Statement To the extent that statements in this presentation are not strictly historical, including statements
More informationSchematic Of Heparin Induced Thrombocytopenia Platelet Count
Schematic Of Heparin Induced Thrombocytopenia Platelet Count Normal IgG and IgG2 differentially inhibit HIT antibody-dependent platelet activation that platelet counts were lower in FcγRIIA 131RR patients
More informationHyperalimentation Associated Hepatotoxicity in the Newborn*
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 22, No. 2 Copyright 1992, Institute for Clinical Science, Inc. Hyperalimentation Associated Hepatotoxicity in the Newborn* JAN M. GOPLERUD, M.D. D ivision
More informationGUIDELINES FOR THE TRANSFUSION OF BLOOD COMPONENTS
CHILDREN S HOSPITALS AND CLINICS OF MINNESOTA Introduction: GUIDELINES FOR THE TRANSFUSION OF BLOOD COMPONENTS These guidelines have been developed in conjunction with the hospital Transfusion Committee.
More informationEctopic Hormone Production by Malignant Tumors
ANNALS O F CLINICAL AND LABORATORY SCIENCE, Vol. 9, No. 4 Copyright 1979, Institute for Clinical Science, Inc. Ectopic Hormone Production by Malignant Tumors IRW IN J. H O LLA N D ER, M.D. and GONZALO
More informationSession II New Developments in the Classification and Diagnosis of VWD. Phenotypic classification of von Willebrand disease
Session II New Developments in the Classification and Diagnosis of VWD Phenotypic classification of von Willebrand disease [haematologica reports] 2005;1(4):9-15 ULRICH BUDDE From the Coagulation Laboratory,
More informationHEPARIN-INDUCED THROMBOCYTOPENIA (HIT)
HEPARIN-INDUCED THROMBOCYTOPENIA (HIT) OBJECTIVE: To assist clinicians with the investigation and management of suspected and documented heparin-induced thrombocytopenia (HIT). BACKGROUND: HIT is a transient,
More informationH yperglycem ic M acrocytosis in Electronically D eterm ined M ean Corpuscular Volume
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 15, No. 4 Copyright 1985, Institute for Clinical Science, Inc. H yperglycem ic M acrocytosis in Electronically D eterm ined M ean Corpuscular Volume Use
More informationTTC Catalog - Respiratory Care (RES)
2018-2019 TTC Catalog - Respiratory Care (RES) RES 110 - Cardiopulmonary Science I This course focuses on assessment, treatment evaluation of patients with cardiopulmonary disease. RES 121 Restrictions:
More information10/24/2013. Heparin-Induced Thrombocytopenia (HIT) Anticoagulation Management in ECMO Therapy:
Anticoagulation Management in ECMO Therapy: Heparin-Induced (HIT) Michael H. Creer, MD Professor of Pathology Director, Clinical Laboratories, Medical Co- Director, Hematopathology and Chief, Division
More informationApproach To A Bleeding Patient
ABDUL MAJEED, RAHUL RAJEEV REVIEW ARTICLE INTRODUCTION Hemostasis is the process of forming clots in the walls of damaged blood vessels and preventing blood loss while maintaining blood in a fluid state
More informationEFFECT OF ORAL WATER SOLUBLE VITAMIN K ON PIVKA-II LEVELS IN NEWBORNS
EFFECT OF ORAL WATER SOLUBLE VITAMIN K ON PIVKA-II LEVELS IN NEWBORNS R.K. Sharma N. Marwaha P. Kumar A. Narang ABSTRACT Intramuscular administration of vitamin K for prophylaxis against hemorrhagic disease
More informationINTRAVENOUS FLUID THERAPY
INTRAVENOUS FLUID THERAPY PRINCIPLES Postnatal physiological weight loss is approximately 5 10% in first week of life Preterm neonates have more total body water and may lose 10 15% of their weight in
More informationNIH Public Access Author Manuscript Clin Chem. Author manuscript; available in PMC 2013 August 05.
NIH Public Access Author Manuscript Published in final edited form as: Clin Chem. 2012 June ; 58(6): 1010 1018. doi:10.1373/clinchem.2011.179200. Clinical Measurement of von Willebrand Factor by Fluorescence
More informationAssessment of Results of Estrogen and Progesterone Receptor Assays Performed in a Community Hospital
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 16, No. 4 Copyright 1986, Institute for Clinical Science, Inc. Assessment of Results of Estrogen and Progesterone Receptor Assays Performed in a Community
More informationU se o f Cerebrospinal Fluid Lactic Acid Concentration in the Diagnosis of Fungal M eningitis
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 17, No. 6 Copyright 1987, Institute for Clinical Science, Inc. U se o f Cerebrospinal Fluid Lactic Acid Concentration in the Diagnosis of Fungal M eningitis
More informationClinical Implications of the Impact of Serum Tissue Factor Levels after Trauma
Clinical Implications of the Impact of Serum Tissue Factor Levels after Trauma Ian E. Brown, MD, PhD, and Joseph M. Galante MD, FACS Formatted: Font: 16 pt, Bold Formatted: Centered Formatted: Font: Bold
More informationDVT PROPHYLAXIS IN HOSPITALIZED MEDICAL PATIENTS SAURABH MAJI SR (PULMONARY,MEDICINE)
DVT PROPHYLAXIS IN HOSPITALIZED MEDICAL PATIENTS SAURABH MAJI SR (PULMONARY,MEDICINE) Introduction VTE (DVT/PE) is an important complication in hospitalized patients Hospitalization for acute medical illness
More informationAnti-inflammatory properties of SM04690, a small molecule inhibitor of the Wnt pathway as a potential treatment for knee osteoarthritis
Anti-inflammatory properties of SM04690, a small molecule inhibitor of the Wnt pathway as a potential treatment for knee osteoarthritis V. Deshmukh 1, T. Seo 1, C. Swearingen 1, Y. Yazici 1 1 Samumed,
More informationHemoglobin Variant Detection from Dried Blood Specimens by High Performance Liquid Chromatography*!
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 23, No. 6 Copyright 1993, Institute for Clinical Science, Inc. Hemoglobin Variant Detection from Dried Blood Specimens by High Performance Liquid Chromatography*!
More informationBPD. Neonatal/Pediatric Cardiopulmonary Care. Disease. Bronchopulmonary Dysplasia. Baby Jane
1 Neonatal/Pediatric Cardiopulmonary Care Disease 2 Bronchopulmonary Dysplasia 3 is a 33-day-old prematurely born girl who weighs 1420 g. At birth, her estimated gestational age was 28 weeks. Her initial
More informationWhole Blood Viscosity in Beta Thalassemia Minor
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 22, No. 4 Copyright 1992, Institute for Clinical Science, Inc. Whole Blood Viscosity in Beta Thalassemia Minor JAMES P. CROWLEY, M.D.t, JACLYN B. M ETZGER,
More informationPlatelet Satellitosis: A Case Report with Laboratory Characterization and Quantitative Evaluation*
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 9, No. 2 Copyright 1979, Institute for Clinical Science, Inc. Platelet Satellitosis: A Case Report with Laboratory Characterization and Quantitative Evaluation*
More informationUniversity of Groningen. Blood platelets in liver transplantation Pereboom, Ilona Tapke Annie
University of Groningen Blood platelets in liver transplantation Pereboom, Ilona Tapke Annie IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
More informationEvaluation of Three Methods of Protein Analysis for Serum and Heart Homogenates
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 9, No. 2 Copyright 1979, Institute for Clinical Science, Inc. Evaluation of Three Methods of Protein Analysis for Serum and Heart Homogenates JON ATH AN
More informationHAEMOLYTIC DISEASE OF THE NEWBORN
SERUM ENZYME CTVTY N PREMTURTY ND N HEMOLYTC DSESE OF THE NEWBORN BY M. BREND MORRS and J. KNG From the Paediatric and Pathology Departments, North Lonsdale Hospital, the Barro and Furness Hospital Group
More informationHypoglycaemia of the neonate. Dr. L.G. Lloyd Dept. Paediatrics
Hypoglycaemia of the neonate Dr. L.G. Lloyd Dept. Paediatrics Why is glucose important? It provides 60-70% of energy needs Utilization obligatory by red blood cells, brain and kidney as major source of
More informationBRONCHOPULMONARY DYSPLASIA
BRONCHOPULMONARY DYSPLASIA CHRONIC NEONATAL LUNG DISEASE (CLD) 2 2 nd BERLIN NEONATOLOGY SUMMER SCHOOL September 2014 3 Mt. Scopus 4 Ein Kerem 5 BRONCHOPULMONARY DYSPLASIA 1960: Ventilation of Neonates
More informationC haracterization of Serum Alkaline Phosphatase o f Hepatobiliary an d O steoblastic O rigin *
A n n a l s o f C l i n i c a l L a b o r a t o r y S c i e n c e, Vol. 3, N o. 3 Copyright 1 973, Institute for Clinical Science C haracterization of Serum Alkaline Phosphatase o f Hepatobiliary an d
More informationINTERLEUKIN-8 IN BRONCHOALVEOLAR LAVAGE FLUID OF PREMATURE INFANTS AT RISK OF CHRONIC LUNG DISEASE
INTERLEUKIN-8 IN BRONCHOALVEOLAR LAVAGE FLUID OF PREMATURE INFANTS AT RISK OF CHRONIC LUNG DISEASE Bai-Horng Su, Hsiao-Yu Chiu, Tsung-Wen Lin, and Hung-Chih Lin Background and Purpose: Persistence of neutrophils
More informationBLEEDING DISORDERS Simple complement:
BLEEDING DISORDERS Simple complement: 1. Select the statement that describe the thrombocytopenia definition: A. Marked decrease of the Von Willebrandt factor B. Absence of antihemophilic factor A C. Disorder
More informationProtein MultiColor Stable, Low Range
Product Name: DynaMarker Protein MultiColor Stable, Low Range Code No: DM670L Lot No: ******* Size: 200 μl x 3 (DM670 x 3) (120 mini-gel lanes) Storage: 4 C Stability: 12 months at 4 C Storage Buffer:
More information7th International Congress of the Spanish Society of Obesity Surgery. Valladolid Spain May, 2004.
7th International Congress of the Spanish Society of Obesity Surgery. Valladolid Spain May, 2004. DIMINISHING POSTOPERATIVE RISKS OF GASTRIC BYPASS Stenosis Stenosis Leak Leak Bleeding Bleeding Stenosis
More informationMcMASTER NICU INHALED STEROIDS FOR EVOLVING BPD (GA < 29 WEEKS)
McMASTER NICU INHALED STEROIDS FOR EVOLVING BPD (GA < 29 WEEKS) Developed by: Amit Mukerji, Samira Samiee-Zafarghandy, Jennifer Twiss, Ereny Bassilious, Elizabeth Vo, Shari Gray, Salhab el Helou on behalf
More informationEvaluation of cryoprecipitate as part of The quality. assurance in the Iraqi National Blood Transfusion Centre
Original Article Evaluation of cryoprecipitate as part of The quality Saad Shawqi Mansoor, FRCPpath * Subh S.Al-Mudallal, FICMShaem** Mohammed Fatih Hassb, FICMShaem** Summary: Background:- Cryoprecipitate
More informationMinimal Enteral Nutrition
Abstract Minimal Enteral Nutrition Although parenteral nutrition has been used widely in the management of sick very low birth weight infants, a smooth transition to the enteral route is most desirable.
More information